NCT07280013 2026-03-05
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
C4 Therapeutics, Inc.
Phase 1 Recruiting
Clinical Trials
4 trialsNCT07106684 2025-08-06
CAREMM-004
Institute of Hematology & Blood Diseases Hospital, China
Phase 2 Recruiting
NCT07106710 2025-08-06
CAREMM-005
Institute of Hematology & Blood Diseases Hospital, China
Phase 2 Recruiting
NCT07106736 2025-08-06
MAGIC-TIEMM
Institute of Hematology & Blood Diseases Hospital, China
Phase 2 Recruiting